Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors

被引:10
|
作者
Zhou, Xuan [1 ]
Zhang, Xueyan [1 ]
Zhong, Tangsheng [1 ]
Zhou, Meng [1 ]
Gao, Lan [2 ,4 ]
Chen, Li [1 ,3 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Changchun, Peoples R China
[3] Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China
[4] First Hosp Jilin Univ, 71 Xinmin St, Changchun 130031, Jilin, Peoples R China
关键词
breast cancer; chemotherapy-related cognitive impairment; nursing; systematic review; older adults; CHEMOBRAIN; ADULTS; AGE;
D O I
10.1111/jan.15842
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
AimsTo examine the prevalence and associated factors of chemotherapy-related cognitive impairment (CRCI) in older breast cancer survivors (BCS).DesignSystematic review.Data SourcesWe searched EMBASE, PubMed, PsychInfo, CINAHL, Cochrance Library, Web of Science, CNKI and SinoMed, without language restrictions, for studies published from the establishment of the database to September 2022.Review MethodsTwo researchers independently examined the full texts, data extraction and quality assessment, and any discrepancies were resolved through discussion with a third reviewer. Quality of evidence was assessed using the Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality Scale.ResultsThe seven included studies showed that the estimated prevalence of CRCI in older BCS ranged from 18.6% to 27% on objective neuropsychological tests and from 7.6% to 49% on subjective cognitive assessments. The areas most affected were attention, memory, executive functioning and processing speed. CRCI was associated with 10 factors in six categories, including sociodemographic (e.g. age, education level), physiological (e.g. sleep disorders, fatigue and comorbidities), psychological (e.g. anxiety, depression), treatment modalities (e.g. chemotherapy cycles, chemotherapy regimens), genetic (e.g. APOE2, APOE4) and lifestyle factor (e.g. physical inactivity).ConclusionCRCI is multifactorial and has a relatively high prevalence. However, the results of subjective and objective cognitive examinations were inconsistent, possibly due to variations in tools used to evaluate different definitions of CRCI. Nevertheless, as there are few published studies of older BCS, this conclusion still require verification by well-designed studies in the future.ImpactWe found that the prevalence of CRCI in older adults is relatively high and multifactorial, providing evidence for further health care for this population.No Patient or Public ContributionThere was no patient or public involvement.
引用
收藏
页码:484 / 499
页数:16
相关论文
共 50 条
  • [31] In Regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors"
    Zarrella, Giuliana V.
    Braun, Sarah E.
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [32] Prevalence of cognitive impairment and associated factors in older people
    Campos, Ana Carolina Brunatto Falchetti
    Teixeira, Iara Gonsalves
    Moraes, Nayara de Souza
    Cadorin, Isabela de Jesus
    Morelli, Patricia Mariotto
    Lidio, Adrielly Vargas
    Medeiros, Eduarda Behenck
    Garcez, Michelle Lima
    Keller, Gabriela Serafim
    Kucharska, Ewa
    da Rosa, Maria Ines
    Ceretta, Luciane Bisognin
    Quevedo, Joao
    Budni, Josiane
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 355 : 283 - 289
  • [33] Prevalence of cognitive impairment and associated factors in older people
    Campos, Ana Carolina Brunatto Falchetti
    Teixeira, Iara Goncalves
    Moraes, Nayara de Souza
    Cadorin, Isabela de Jesus
    Morelli, Patricia Mariotto
    Lidio, Adrielly Vargas
    Medeiros, Eduarda Behenck
    Garcez, Michelle Lima
    Keller, Gabriela Serafim
    Kucharska, Ewa
    da Rosa, Maria Ines
    Ceretta, Luciane Bisognin
    Quevedo, Joao
    Budni, Josiane
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 355 : 283 - 289
  • [34] Construction and validation of a risk-prediction model for chemotherapy-related cognitive impairment in patients with breast cancer
    Liu, Yu
    Li, Ruo-Lin
    Chen, Lu
    Zhao, Fu-Yun
    Su, Ya-Li
    Jin, Shuai
    Liu, Jun-E
    JOURNAL OF CANCER SURVIVORSHIP, 2024,
  • [35] Chemotherapy-related subjective cognitive impairment in breast cancer patients in semi-rural South Africa
    Keetile, Nicholas M.
    Osuch, Elzbieta
    Lentoor, Antonio G.
    HEALTH SA GESONDHEID, 2021, 26
  • [36] Imaging as a Means of Studying Chemotherapy-Related Cognitive Impairment
    Raffa, Robert B.
    CHEMO FOG: CANCER CHEMOTHERAPY-RELATED COGNITIVE IMPARIMENT, 2010, 678 : 70 - 76
  • [37] Functional connectome biotypes of chemotherapy-related cognitive impairment
    Kesler, Shelli R.
    Petersen, Melissa L.
    Rao, Vikram
    Harrison, Rebecca A.
    Palesh, Oxana
    JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (04) : 483 - 493
  • [38] Functional connectome biotypes of chemotherapy-related cognitive impairment
    Shelli R. Kesler
    Melissa L. Petersen
    Vikram Rao
    Rebecca A. Harrison
    Oxana Palesh
    Journal of Cancer Survivorship, 2020, 14 : 483 - 493
  • [39] Brain PET in Elucidation of Mechanisms Underlying Cancer/Chemotherapy-Related Cognitive Impairment
    Beal, Maya
    Silverman, Daniel
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [40] Cognitive function in older breast cancer survivors after chemotherapy
    Kim, Rachel
    Liao, Kai-Ping
    Peterson, Susan
    Zorzi, Daria
    Li, Liang
    MacGregor, Mariana Chavez
    Giordano, Sharon
    CANCER RESEARCH, 2024, 84 (06)